El Salvador vs Sri Lanka: Access to anti-retroviral drugs, female
El Salvador
74.0%
in 2024
Sri Lanka
73.0%
in 2024
El Salvador rank
69th
Sri Lanka rank
71st
Access to anti-retroviral drugs, female over time
- El Salvador
- Sri Lanka
How they compare
El Salvador currently reports 74.0% against 73.0% in Sri Lanka, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Sri Lanka ahead.
El Salvador ranks 69th and Sri Lanka ranks 71st of 141 countries.
El Salvador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | El Salvador | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.9% | 2.2% | 9.7% | El Salvador |
| 2010s | 64.3% | 23.9% | 40.4% | El Salvador |
| 2020s | 74.2% | 60.4% | 13.8% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, El Salvador or Sri Lanka?
- El Salvador, at 74.0% against 73.0% in Sri Lanka as of 2024.
- What is the difference in access to anti-retroviral drugs, female between El Salvador and Sri Lanka?
- 1.0%, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and Sri Lanka?
- 25 years are reported by both, from 2000 to 2024.
- How do El Salvador and Sri Lanka rank globally for access to anti-retroviral drugs, female?
- El Salvador ranks 69th and Sri Lanka ranks 71st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.